Topic - Robert Coleman

Subscribe to this topic via RSS or ATOM
Related Stories
  • Bone drug Zometa flops in breast cancer study

    One of the most promising new approaches for fighting breast cancer took a stunning setback Thursday when a major study showed that a bone-building drug did not stop cancer from returning or extend life for most women fighting the disease.

More Stories →

Happening Now